Genus (CHIX:GNSL) Notes Receivable: £0.0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:GNSL Genus PLC CHIX:GNSL
73 GF Score
Price £20.28
GF Value £20.75
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Genus Notes Receivable?

Genus CHIX:GNSL +0.75% 73 Notes Receivable is £0.0 Mil as of Dec. 2025. GuruFocus rates CHIX:GNSL with a GF Score™ of 73/100 and a GF Value™ of £20.75 (Fairly Valued). The stock has 5 warning signs investors should review.

Genus's Notes Receivable for the quarter that ended in Dec. 2025 was £0.0 Mil.

Genus Notes Receivable Historical Data

* Premium members only.

The historical data trend for Genus's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genus Notes Receivable Chart

Genus Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Genus Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
CHIX:GNSL
73GF Score
Genus PLC CHIX:GNSL
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Genus Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of £0.0 Mil mean?
Genus (CHIX:GNSL) has a Notes Receivable of £0.0 Mil as of Dec. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Genus and its competitors.
Is Genus' Notes Receivable too high?
Genus' current Notes Receivable is £0.0 Mil. Overall, Genus has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Genus' Notes Receivable compare to VRTX and REGN?
Genus' Notes Receivable of £0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Biotechnology company?
A good Notes Receivable depends on the Biotechnology industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Genus and its competitors. Genus's current Notes Receivable is £0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genus stock overvalued right now?
Based on GuruFocus' analysis, Genus (CHIX:GNSL) is currently considered Fairly Valued. The stock's GF Value™ is £20.75, compared to a current price of £20.28 — trading 2.3% below its estimated fair value. The current Notes Receivable is £0.0 Mil. Genus' overall GF Score™ is 73/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Genus (CHIX:GNSL), the current Notes Receivable is £0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Genus (CHIX:GNSL) Overvalued in 2026?

Based on GuruFocus' analysis, Genus stock appears to be undervalued. The current stock price of £20.28 is trading 2.3% below its estimated GF Value™ of £20.75. GuruFocus considers Genus to be Fairly Valued.

Key valuation signals for CHIX:GNSL:

  • Notes Receivable: £0.0 Mil
  • GF Value™: £20.75 vs. price of £20.28 (2.3% below fair value)
  • GF Score™: 73/100 with 5 warning signs

No single metric tells the full story. See the CHIX:GNSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Genus Business Description

Address Matrix House, Basing View, Basingstoke, Hampshire, GBR, RG21 4FF
Genus PLC is an animal genetics company focused on improving cattle and pig populations to support sustainable food production. The company operates through two main business units: one providing bovine genetics mainly for dairy and beef cattle, and the other offering porcine genetics for pork production. Genus develops genetically superior breeding animals using scientific techniques. It generates revenue by selling genetics, including semen and embryos, as well as through related services under multi-year royalty agreements. The principal activities of each segment are: (a) Genus PIC porcine sales business, (b) Genus ABS: bovine sales business, and (c) Genus Research and Development: spending on research and development.
73GF Score

Get the complete analysis for CHIX:GNSL

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£20.28
Price
£20.75
GF Value